Evidence map›Paper›PMID 35402931›Full record

ArticleDelaware journal of public health2022

Pediatric Vaccines:: What's New for 2022.

Michelle Eng, Liza Hashim

Open access · bronzeAbstract read
In one paragraph

Article in Delaware journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michelle EngPGY-3 Pediatric Residents, Nemours Children's Hospital-Delaware.
Liza HashimPGY-3 Pediatric Residents, Nemours Children's Hospital-Delaware.
Nemours Children's Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood immunizations have proven to be tremendously successful in eradicating diseases that have previously been considered to be fatal. Though current immunizations are generally well tolerated, it is important to constantly evaluate existing methods and be amenable to changes when they present. Newer formulations of products have been in development to improve vaccine completion, vaccine efficacy, and protection against emerging diseases. Growing interest in health economics has led to production of new vaccines that promote healthier outcomes in all populations, especially those vulnerable to infectious disease, children.

Identifiers

PMID35402931
PMCPMC8982923
OpenAlexW4220757660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.